Renalogic

Renalogic, founded in 2002 and operating across the United States, provides chronic kidney disease (CKD) risk management and dialysis cost containment services for self-funded health plans. The company combines NCQA-accredited population health management clinical services with cost containment strategies, drawing on work in data-driven risk identification, clinical case management, renal disease clinical care and ERISA and healthcare law.

Its offerings include ImpactCare, a proactive and preventive programme designed to delay or reverse CKD progression through early detection, clinical support services and administrative guidance. Renalogic reports that the programme is 230% more effective at identifying undiagnosed CKD and achieves a 30% reduction in emergent dialysis starts. Alongside it sits a CKD risk management methodology and pioneering dialysis cost containment services, delivered as an end-to-end solution over more than two decades. The company cites industry context in which dialysis often costs more than $100,000 per patient a year.

The firm employs a multidisciplinary team spanning healthcare administration leaders, case managers, clinical renal experts and ERISA and healthcare legal specialists. It describes its approach as data-driven and results-oriented, with an emphasis on measurable outcomes and proactive, preventive care, and positions itself as a long-term partner to self-funded plans in the healthcare, employee benefits and renal care sectors.